Add like
Add dislike
Add to saved papers

Heterogeneous activation of peroxymonosulfate by hierarchical CuBi 2 O 4 to generate reactive oxygen species for refractory organic compounds degradation: morphology and surface chemistry derived reaction and its mechanism.

Activation of peroxymonosulfate (PMS) by a novel hierarchical CuBi2 O4 generated reactive oxygen radical for degradation refractory organic compounds in aqueous solution, which would be controlled by the morphology and surface chemistry of solid catalyst. It's found that the activation ability of CuBi2 O4 toward PMS was highly dependent on the morphology and surface hydroxyl group, as using rhodamine B (RhB) as the model compound. The spherical CuBi2 O4 , which possessed higher density of surface hydroxyl group, exhibited better catalytic activity in RhB degradation than scattered cluster CuBi2 O4 , and as-prepared CuBi2 O4 could efficiently activated PMS to degrade RhB within a wide pH range as an absolute heterogeneous process. The emerging organic chemicals, including bisphenol A, 1H-benzotriazole, and carbamazepine, could also be effectively removed in this novel CuBi2 O4 /PMS. Furthermore, activation mechanism of PMS by as-prepared CuBi2 O4 was proposed, the existence of surface hydroxyl group bonded with Cu(II), and inward electron transfer cycling reaction between Cu(II)/Cu(I) facilitated the effective activation of PMS to generate SO4 ·- and ·OH. In addition, the intermediates of RhB formed in this process were identified by silylation derivatation-GC-MS and LC-high-resolution MS/MS, and degradation pathway was proposed.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app